JOHN STANFORD: Open Payments
NPI 1881286995 · TULSA, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,434 in 28 payments from 9 companies in 2025. Trend: 2023 $1,436 · 2024 $2,021 · 2025 $1,434
Food & beverage: $1,376Honoraria: $58
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $275 |
| ABBVIE INC. | 13 | $257 |
| Teva Pharmaceuticals USA, Inc. | 2 | $235 |
| Alkermes, Inc. | 2 | $231 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Axsome Therapeutics, Inc. | 1 | $89 |
| Becton, Dickinson and Company | 1 | $58 |
| Corium, LLC | 4 | $45 |
Products named: SPRAVATO, VRAYLAR, COBENFY, REXULTI, AUSTEDO XR, LYBALVI, UZEDY, VIVITROL.
Industry payments across OK — which companies pay providers there.
